QR kȏd

Novel metabolic subtypes in IDH-mutant gliomas: implications for prognosis and therapy

Abstract Background Although IDH-mutant glioma generally has a better prognosis than their IDH-wildtype counterparts, considerable prognostic heterogeneity persists among patients with the same IDH mutation. Current study has primarily focused on the different IDH statuses or grades, while the metab...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Peng Wang, Jiayi Wang, Zheng Fang, Qiaodong Chen, Ying Zhang, Xiaoguang Qiu, Zhaoshi Bao
Format: Artigo
Jezik:Inglês
Izdano: BMC 2025-04-01
Serija:BMC Cancer
Teme:
Online pristup:https://doi.org/10.1186/s12885-025-14176-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!